New painkiller mirogabalin takes on diabetic nerve pain

NCT ID NCT07451431

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether mirogabalin can reduce nerve pain in people with diabetes. 78 adults will take either mirogabalin or the standard drug pregabalin daily for 8 weeks. Researchers will measure pain levels, side effects, and quality of life to see if mirogabalin is a better option.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Mirogabalin

What this could lead to

If it works, mirogabalin could offer a new option for managing diabetic nerve pain with possibly fewer side effects.

What could go wrong

This is a small, early-phase trial comparing to an existing drug, so results may not confirm superiority or long-term safety.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC PERIPHERAL NEUROPATHIC PAIN (DPNP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetic neuropathy diabetic polyneuropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Bangladesh Medical University

    RECRUITING

    Dhaka, 1000, Bangladesh

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••